Table 2.
Facility Characteristics
Public | Medicine retailer | Total | |||||
---|---|---|---|---|---|---|---|
HEALTH FACILITIES | N = 20 | % | N = 80 | % | N = 100 | % | P value |
Equipment and services available | |||||||
Weighing scale† | 19 | 94.1 | 36 | 50.0 | 55 | 53.1 | <0.001 |
Thermometer | 19 | 94.2 | 35 | 46.5 | 54 | 49.8 | <0.001 |
Microscopy services† | 3 | 12.8 | 0 | - | 3 | 0.9 | <0.001 |
RDT | 0 | - | 0 | - | 0 | - | - |
Availability of anti-malarials | |||||||
Any anti-malarial | 20 | 100.0 | 80 | 100.0 | 100 | 100.0 | - |
Artesunate monotherapy | 5 | 24.6 | 76 | 96.1 | 81 | 91.1 | <0.001 |
Sulphadoxine Pyrimethamine (SP) † | 18 | 89.8 | 71 | 89.9 | 89 | 89.9 | 0.982 |
Chloroquine | 14 | 71.1 | 77 | 96.8 | 91 | 95.0 | <0.001 |
Quinine | 4 | 20.3 | 70 | 89.1 | 74 | 84.3 | <0.001 |
Amodiaquine | 3 | 14.4 | 60 | 85.3 | 63 | 80.3 | <0.001 |
Any type of ACT | 14 | 71.1 | 66 | 89.6 | 80 | 88.3 | <0.001 |
Artemether Lumefantrine (AL) | 12 | 65.6 | 64 | 79.6 | 66 | 78.4 | <0.001 |
Artesunate Amodiaquine (ASAQ) | 2 | 8.6 | 57 | 78.8 | 59 | 73.9 | <0.001 |
Artesunate Mefloquine (ASMQ) | 0 | - | 35 | 52.9 | 35 | 49.2 | <0.001 |
Artesunate Sulphadoxine-Pyrimethamine (ASSP) | 0 | - | 18 | 28.4 | 18 | 26.4 | <0.001 |
Dihydroartemisinin-Piperaquine (DHAPQ) | 0 | - | 55 | 78.0 | 55 | 72.6 | <0.001 |
Median cost of ACT (& IQ range) | |||||||
Adult dose of any ACT | - | 600 (350, 750) | 600 (350, 750) | - | |||
Child dose of any ACT | - | 350 (260, 600) | 350 (250, 600) | - | |||
Adult dose of AL | - | 750 (650, 835) | 750 (650, 820) | - | |||
Child dose of AL | - | 650 (580, 750) | 650 (520, 700) | - | |||
HEALTH WORKERS | N = 50 | % | N = 99 | % | N = 149 | % | P value |
Doctor | 7 | 14.0 | 0 | 9 | 1.7 | <0.001 | |
Nurse or Midwife | 7 | 14.0 | 7 | 7.3 | 14 | 8.1 | |
Community Health Officer | 14 | 28.0 | 1 | 1.3 | 15 | 4.5 | |
Community Health Extension Worker | 22 | 44.0 | 3 | 4.1 | 25 | 8.9 | |
Pharmacist‡ | - | 3 | 3.9 | 3 | 3.4 | ||
PMD or pharmacy attendant‡ | - | 85 | 83.4 | 85 | 73.5 | ||
HW has attended malaria training in past 3 years | 13 | 24.6 | 31 | 33.0 | 44 | 31.9 | 0.011 |
HW has access to malaria treatment guidelines | 15 | 30.9 | 4 | 5.2 | 19 | 8.5 | <0.001 |
HW accurately reported ACTs are the recommended treatment for uncomplicated malaria | 38 | 77.2 | 44 | 62.2 | 82 | 65.4 | <0.001 |
† missing response from one pharmacy
‡ not applicable in public facilities